Coherus Biosciences | CHRS - Market Capitalization


Coherus Biosciences reported $161.7M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 434.77B 50.08B Aug/2026
Acadia Pharmaceuticals USD 3.8B 724M Mar/2026
Akebia Therapeutics USD 427M 297M Dec/2025
ALKERMES USD 7.93B 806M Aug/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amarin USD 290M 51M Dec/2025
Amgen USD 189.89B 13.64B Mar/2026
Baxter International USD 11.01B 2.34B Jun/2026
Biogen USD 31.9B 5B Jun/2026
BioMarin Pharmaceutical USD 10.86B 553M Mar/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Coherus Biosciences USD 172M 19M Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Fujifilm JPY 3.69T 340.04B Mar/2026
Gilead Sciences USD 172.99B 20.71B Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Pacira USD 915M 149M Mar/2026
Perrigo USD 1.31B 604M Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Sarepta Therapeutics USD 2.28B 30M Mar/2026
Teva Pharmaceutical Industries USD 114.54B 80.27B Jun/2026
Vertex Pharmaceuticals USD 121.79B 8.21B Aug/2026
Xencor USD 893M 200M Mar/2026
Zoetis USD 49.71B 5.74B Mar/2026